Skip to content

Dasiglucagon

DRUG17 trials

Sponsors

Zealand Pharma, Massachusetts General Hospital, Steno Diabetes Center Copenhagen, Filip Krag Knop, Inreda Diabetic B.V.

Conditions

Congenital HyperinsulinismDiabetes Mellitus, Type 1Glucose Metabolism DisordersHyperinsulinemic HypoglycemiaHypoglycemiaPostprandial HypoglycemiaType 1 DiabetesType 1 Diabetes Mellitus

Phase 1

Phase 2

Phase 3

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
CompletedNCT03216226
Zealand PharmaDiabetes Mellitus, Type 1, Hypoglycemia
Start: 2017-06-28End: 2018-02-13Updated: 2021-05-04
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
CompletedNCT03378635
Zealand PharmaDiabetes Mellitus, Type 1, Hypoglycemia
Start: 2017-12-07End: 2018-05-25Updated: 2021-06-10
Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
CompletedNCT03667053
Zealand PharmaHypoglycemia
Start: 2018-09-28End: 2019-06-28Updated: 2021-06-30
Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
CompletedNCT03688711
Zealand PharmaDiabetes Mellitus, Type 1, Hypoglycemia
Start: 2018-11-01End: 2019-03-11Updated: 2021-05-19
A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
CompletedNCT03777176
Zealand PharmaCongenital Hyperinsulinism
Start: 2019-02-07End: 2020-10-05Updated: 2023-12-13
A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
CompletedNCT03895697
Zealand PharmaDiabetes Mellitus, Type 1, Hypoglycemia
Start: 2019-03-26End: 2019-07-30Updated: 2023-02-21
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism
Active, not recruitingNCT03941236
Zealand PharmaCongenital Hyperinsulinism
Start: 2019-05-02End: 2026-12-31Updated: 2026-01-20
A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D
CompletedNCT05378672
Zealand PharmaHypoglycemia, Type 1 Diabetes
Start: 2023-05-09End: 2024-12-03Updated: 2025-07-20

Related Papers